Federated Hermes Inc. decreased its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 36.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 630,500 shares of the construction company's stock after selling 368,100 shares during the period. Federated Hermes Inc. owned about 0.77% of Aspen Aerogels worth $7,490,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently modified their holdings of ASPN. AlphaQuest LLC increased its holdings in Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock valued at $135,000 after purchasing an additional 3,998 shares in the last quarter. KLP Kapitalforvaltning AS bought a new position in shares of Aspen Aerogels in the fourth quarter valued at about $164,000. Journey Strategic Wealth LLC acquired a new position in Aspen Aerogels during the 4th quarter worth about $178,000. Ballentine Partners LLC grew its holdings in Aspen Aerogels by 19.2% during the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock worth $189,000 after acquiring an additional 2,565 shares during the last quarter. Finally, Aigen Investment Management LP acquired a new stake in Aspen Aerogels in the 4th quarter valued at about $219,000. Institutional investors own 97.64% of the company's stock.
Aspen Aerogels Trading Down 2.8 %
Shares of NYSE:ASPN traded down $0.15 during trading on Tuesday, reaching $5.16. The stock had a trading volume of 845,671 shares, compared to its average volume of 1,892,820. Aspen Aerogels, Inc. has a 52 week low of $4.80 and a 52 week high of $33.15. The firm's fifty day moving average is $7.47 and its 200 day moving average is $12.84. The stock has a market cap of $423.66 million, a price-to-earnings ratio of 32.25 and a beta of 2.35. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, equities analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on ASPN shares. Seaport Res Ptn lowered Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 12th. Barclays reduced their target price on shares of Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 19th. StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a research note on Wednesday, February 19th. Canaccord Genuity Group dropped their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a research report on Friday, February 14th. Finally, Roth Mkm decreased their price objective on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, one has given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Aspen Aerogels has an average rating of "Moderate Buy" and a consensus target price of $19.11.
Get Our Latest Research Report on ASPN
Aspen Aerogels Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Further Reading

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.